Skip to main content
. 2020 Aug 27;9(17):e017039. doi: 10.1161/JAHA.120.017039

Table 2.

Association of APOL1 Risk Status With Subclinical Measures of Vascular and Endothelial Function at MESA Exam 1

C2
n

Mean (SD)

mL/mm Hg×100

Model 1

β (95% CI)

Model 2

β (95% CI)

APOL1 low‐risk 1393 4.20 (2.55) 0.00 (ref) 0.00 (ref)
APOL1 high‐risk 193 4.01 (2.30) −0.15 (−0.55, 0.25) −0.11 (−0.47, 0.24)
P value 0.33 0.47 0.54
C1
n

Mean (SD)

mL/mm Hg×10

Model 1

β (95% CI)

Model 2

β (95% CI)

APOL1 low‐risk 1393 13.49 (5.88) 0.00 (ref) 0.00 (ref)
APOL1 high‐risk 193 13.41 (2.10) −0.06 (−0.98, 0.86) −0.05 (−0.88, 0.78)
P value 0.85 0.90 0.91
AAD
n

Mean (SD)

mm Hg−1×103

Model 1

β (95% CI)

Model 2

β (95% CI)

APOL1 low‐risk 863 1.69 (1.31) 0.00 (ref) 0.00 (ref)
APOL1 high‐risk 122 1.55 (0.75) −0.22 (−0.48, 0.04) −0.21 (−0.46, 0.03)
P value 0.09 0.10 0.09
FMD
N

Mean (SD)

mm

Model 1

β (95% CI)

Model 2

β (95% CI)

APOL1 low‐risk 692 0.15 (0.10) 0.00 (ref) 0.00 (ref)
APOL1 high‐risk 85 0.16 (0.09) 0.01 (−0.02, 0.03) 0.01 (−0.02, 0.03)
P‐value 0.58 0.50 0.56

Model 1 unadjusted. Model 2 adjusted for age, sex, and African ancestry. AAD indicates ascending aortic distensibility; C1, large arterial elasticity; C2, small arterial elasticity; FMD, flow‐mediated dilation; and MESA, Multi‐Ethnic Study of Atherosclerosis.